Epidarex Capital

company

About

Epidarex invests in early-stage, high growth life science and health technology companies in under-ventured markets within the UK and them.

  • 1 - 10

Details

Industries
Angel Investment,Life Science,Venture Capital
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
MVC

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Investments

Number of Investments
Number of Lead Investments
1
1
Epidarex Capital has made 1 investments. Their most recent investment was on Oct 21, 2021, when Leucid Bio raised £11.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 21, 2021 Leucid Bio
Series A £11.50M Biotechnology Yes